Controlled release of tetracycline from biodegradable β-tricalcium phosphate composites

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 92, Issue 2, 2010, Pages 341-352

  Luginbuehl, Vera ^a   Ruffieux, Kurt ^b   Hess, Claudia ^a   Reichardt, Dennis ^b   Von Rechenberg, Brigitte ^c   Nuss, Katja ^c  

^a ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^b Degradable Solutions AG   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

tricalcium phosphate; Bone infections; Bone substitute material; Controlled release; Local antibiotic delivery

Indexed keywords

BONE INFECTION; BONE SUBSTITUTE MATERIAL; BONE SUBSTITUTES; CONTROLLED RELEASE; LOCAL ANTIBIOTIC DELIVERY; TRI-CALCIUM PHOSPHATES;

ANTIBIOTICS; BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; BIODEGRADATION; BONE; CONTROLLED DRUG DELIVERY; CYTOTOXICITY; GENETIC ENGINEERING; ORGANIC POLYMERS; PHOSPHATE COATINGS; PLASTIC COATINGS; POLYMER BLENDS; TRANSMISSION CONTROL PROTOCOL;

THERMAL CONDUCTIVITY;

CALCIUM PHOSPHATE; POLYGLACTIN; POLYMER; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BIODEGRADABILITY; BONE DEFECT; CANCELLOUS BONE; CHEMICAL INTERACTION; CHO CELL; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG COATING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STRUCTURE; FAST DRUG RELEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOSARCOMA CELL; SLOW DRUG RELEASE; SUSTAINED DRUG RELEASE;

ABSORBABLE IMPLANTS; ANIMALS; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; CELL LINE; CELL SURVIVAL; CHO CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; CRICETULUS; DRUG DELIVERY SYSTEMS; GRANULOMA, FOREIGN-BODY; LACTIC ACID; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; POLYGLYCOLIC ACID; SHEEP; TETRACYCLINE;

EID: 74749088239     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31520     Document Type: Article

References (58)

1. Di Silvio L, Bonfield W. Biodegradable drug delivery system for the treatment of bone infection and repair. J Mater Sci Mater Med 1999;10:653-658.
2. Wenke JC, Owens BD, Svoboda SJ, Brooks DE. Effectiveness of commercially-available antibiotic-impregnated implants. J Bone Joint Surg Br 2006;88:1102-1104.
3. Hanssen AD. Local antibiotic delivery vehicles in the treatment of musculoskeletal infection. Clin Orthop Relat Res 2005;91-96.
4. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006;27:2331-2339.
5. Gristina AG. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science 1987;237:1588-1595.
6. Hoff SF, Fitzgerald RH, Kelly PJ. The depot administration of penicillin G and gentamicin in acrylic bone cement. J Bone Joint Surg Am 1981;63:798-804.
7. Hendriks JG, van Horn JR, van Der Mei HC, Busscher HJ. Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection. Biomaterials 2004;25:545-556.
8. Rottger J, Buchholz HW, Engelbrecht E, Siegel A. Gentamycin-PMMA in joint prosthesis. Indication and technic in the use of Refobacin-Palacos in joint prosthesis. Aktuelle Probl Chir Orthop 1979;12:197-200.
9. Rottger J, Buchholz HW, Engelbrecht E, Siegel A. Results with Refobacin-Palacos in the changing of infected prostheses. Results of prostheses exchange under cover of Refobacin-Palacos in Hamburg. Aktuelle Probl Chir Orthop 1979;12:211-213.
10. Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. J Control Release 2008;130:202-215.
11. Norowski PA, Bumgardner JD. Biomaterial and antibiotic strategies for peri-implantitis: A review. J Biomed Mater Res B Appl Biomater 2009;88:530-543.
12. Nelson CL. The current status of material used for depot delivery of drugs. Clin Orthop Relat Res 2004;427:72-78.
13. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis 2003;36:1284-1289.
14. Stallmann HP, Faber C, Bronckers AL, Nieuw Amerongen AV, Wuisman PI. In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile. BMC Musculoskelet Disord 2006;7:18.
15. Queiroz AC, Santos JD, Monteiro FJ. Development of a system to adsorb drugs onto calcium phosphate materials. J Mater Sci Mater Med 2005;16:641-646.
16. Teller M, Gopp U, Neumann HG, Kuhn KD. Release of gentamicin from bone regenerative materials: An in vitro study. J Biomed Mater Res B Appl Biomater 2007;81:23-29.
17. Ethell MT, Bennett RA, Brown MP, Merritt K, Davidson JS, Tran T. In vitro elution of gentamicin, amikacin, and ceftiofur from polymethylmethacrylate and hydroxyapatite cement. Vet Surg 2000;29:375-382.
18. Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements: Competitive drug carriers for the musculoskeletal system? Biomaterials 2006;27:2171-2177.
19. Soriano I, Evora C. Formulation of calcium phosphates/poly (d,l-lactide) blends containing gentamicin for bone implantation. J Control Release 2000;68:121-134.
20. Bohner M, Lemaitre J, Merkle HP, Gander B. Control of gentamicin release from a calcium phosphate cement by admixed poly(acrylic acid). J Pharm Sci 2000;89:1262-1270.
21. Takechi M, Miyamoto Y, Ishikawa K, Nagayama M, Kon M, Asaoka K, Suzuki K. Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement. J Biomed Mater Res 1998;39:308-316.
22. Takechi M, Miyamoto Y, Momota Y, Yuasa T, Tatehara S, Nagayama M, Ishikawa K, Suzuki K. The in vitro antibiotic release from anti-washout apatite cement using chitosan. J Mater Sci Mater Med 2002;13:973-978.
23. Schnieders J, Gbureck U, Thull R, Kissel T. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 2006;27:4239-4249.
24. Jansen J, Bodde EW, Habraken W, Mikos AG, Spauwen PH. Effect of polymer molecular weight on the bone biological activity of biodegradable polymer/calcium phosphate cement composites. Tissue Eng A 2009;15. Forthcoming.
25. Buxton TB, Walsh DS, Harvey SB, Mcpherson JC, Hartmann JF, Plowman KM. Bisphosphonate-ciprofloxacin bound to Skelite is a prototype for enhancing experimental local antibiotic delivery to injured bone. Br J Surg 2004;91:1192-1196.
26. Siegel IA. Pharmacology of antibiotics used in dentistry. Int Dent J 1981;31:133-144.
27. Vandekerckhove BN, Quirynen M, Van Steenberghe D. The use of tetracycline-containing controlled-release fibers in the treatment of refractory periodontitis. J Periodontol 1997;68:353-361.
28. Gates KA, Grad H, Birek P, Lee PI. A new bioerodible polymer insert for the controlled release of metronidazole. Pharm Res 1994;11:1605-1609.
29. Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990;17:479-493.
30. Kuhne M, Ihnen D, Moller G, Agthe O. Stability of tetracycline in water and liquid manure. J Vet Med A Physiol Pathol Clin Med 2000;47:379-384.
31. Fulop M, Drapkin A. Potassium-depletion syndrome secondary to nephropathy apparently caused by "outdated tetracycline". N Engl J Med 1965;272:986-989.
32. Rahn BA, Perren SM. Alizarin complexon-fluorochrome for bone and dentine labeling. Experientia 1972;28:180.
33. Tam CS, Anderson W. Tetracycline labeling of bone in vivo. Calcif Tissue Int 1980;30:121-125.
34. Govender S, Pillay V, Chetty DJ, Essack SY, Dangor CM, Govender T. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. Int J Pharm 2005;306:24-40.
35. Mazur X, Eppenberger HM, Bailey JE, Fussenegger M. A novel autoregulated proliferation-controlled production process using recombinant CHO cells. Biotechnol Bioeng 1999;65:144-150.
36. Schwach-Abdellaoui K, Monti A, Barr J, Heller J, Gurny R. Optimization of a novel bioerodible device based on autocatalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket. Biomaterials 2001;22:1659-1666.
37. Nuss KM, Auer JA, Boos A, von Rechenberg B. An animal model in sheep for biocompatibility testing of biomaterials in cancellous bones. BMC Musculoskelet Disord 2006;7:67.
38. Apelt D, Theiss F, El-Warrak AO, Zlinszky K, Bettschart-Wolfisberger R, Bohner M, Matter S, Auer JA, von Rechenberg B. In vivo behavior of three different injectable hydraulic calcium phosphate cements. Biomaterials 2004;25:1439-1451.
39. von Doernberg MC, von Rechenberg B, Bohner M, Grunenfelder S, van Lenthe GH, Muller R, Gasser B, Mathys R, Baroud G, Auer J. In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials 2006;27:5186-5198.
40. Capote R, Diana J, Roets E, Hoogmartens J. Separation of tetracycline and its impurities by liquid chromatography on XTerra RP-18. J Sep Sci 2002;25:399-404.
41. Carrasco E, Martinez M, Calbacho M, Wilckens M. In vitro activity of amoxicillin, tetracyclines, azithromycin, ofloxacin and metronidazole against Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum strains. Anaerobe 1999;5:443-445.
42. Schwach-Abdellaoui K, Loup PJ, Vivien-Castioni N, Mombelli A, Baehni P, Barr J, Heller J, Gurny R. Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans. AAPS PharmSci 2002;4:E20.
43. Trampuz A, Osmon DR, Hanssen AD, Steckelberg JM, Patel R. Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res 2003;414:69-88.
44. Benoit MA, Mousset B, Delloye C, Bouillet R, Gillard J. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int Orthop 1997;21:403-408.
45. Sakellari D, Goodson JM, Kolokotronis A, Konstantinidis A. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 2000;27:53-60.
46. Klein CP, de Blieck-Hogervorst JM, Wolke JG, de Groot K. Studies of the solubility of different calcium phosphate ceramic particles in vitro. Biomaterials 1990;11:509-512.
47. Baro M, Sanchez E, Delgado A, Perera A, Evora C. In vitroin vivo characterization of gentamicin bone implants. J Control Release 2002;83:353-364.
48. Council of Europe (COE) - European Directorate for the Quality of Medicines. European Pharmacopoeia. Stuttgart: Deutscher Apotheker Verlag; 2005.
49. Patterson A, Holmes D. Long-acting oxytetracycline composition. US Patent 6,110,905, 2000.
50. Hamanishi C, Kitamoto K, Tanaka S, Otsuka M, Doi Y, Kitahashi T. A self-setting TTCP-DCPD apatite cement for release of vancomycin. J Biomed Mater Res 1996;33:139-143.
51. Ge SH, Yang PS, Zhao N, Qi XM, Sun QF, Wang Y. Biological effects of tetracycline on cultured human periodontal fibroblasts. Hua Xi Kou Qiang Yi Xue Za Zhi 2004;22:376-378.
52. Wang Y, Morlandt AB, Xu X, Carnes DL, Chen Z, Steffensen B. Tetracycline at subcytotoxic levels inhibits matrix metalloproteinase-2 and -9 but does not remove the smear layer. J Periodontol 2005;76:1129-1139.
53. Kuemmerle JM, Oberle A, Oechslin C, Bohner M, Frei C, Boecken I, von Rechenberg B. Assessment of the suitability of a new brushite calcium phosphate cement for cranioplasty - An experimental study in sheep. J Craniomaxillofac Surg 2005;33:37-44.
54. Theiss F, Apelt D, Brand B, Kutter A, Zlinszky K, Bohner M, Matter S, Frei C, Auer JA, von Rechenberg B. Biocompatibility and resorption of a brushite calcium phosphate cement. Biomaterials 2005;26:4383-4394.
55. Langhoff JD, Voelter K, Scharnweber D, Schnabelrauch M, Schlottig F, Hefti T, Kalchofner K, Nuss K, von Rechenberg B. Comparison of chemically and pharmaceutically modified titanium and zirconia implant surfaces in dentistry: A study in sheep. Int J Oral Maxillofac Surg 2008;37:1125-1132.
56. Langhoff JD, Mayer J, Faber L, Kaestner SB, Guibert G, Zlinszky K, Auer JA, von Rechenberg B. Does surface anodisation of titanium implants change osseointegration and make their extraction from bone any easier? Vet Comp Orthop Traumatol 2008;21:202-210.
57. Sanchez AR, Rogers RS, Sheridan PJ. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol 2004;43:709-715.
58. Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinatol 2003;20:405-414.